vs
Privia Health Group, Inc.（PRVA）与Teladoc Health, Inc.（TDOC）财务数据对比。点击上方公司名可切换其他公司
Teladoc Health, Inc.的季度营收约是Privia Health Group, Inc.的1.2倍（$642.3M vs $541.2M），Privia Health Group, Inc.同比增速更快（17.4% vs 0.3%），过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs -0.3%）
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
泰莱达克健康是一家跨国远程医疗与虚拟医疗企业，2002年成立，总部位于美国纽约。公司核心业务涵盖远程问诊、医学意见咨询、人工智能与数据分析、远程医疗设备及可授权平台服务，主要通过电话、视频会议软件与移动应用，为用户提供随时可及的远程医疗服务。
PRVA vs TDOC — 直观对比
营收规模更大
TDOC
是对方的1.2倍
$541.2M
营收增速更快
PRVA
高出17.1%
0.3%
两年增速更快
PRVA
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $541.2M | $642.3M |
| 净利润 | $9.2M | — |
| 毛利率 | — | — |
| 营业利润率 | 2.1% | -5.6% |
| 净利率 | 1.7% | — |
| 营收同比 | 17.4% | 0.3% |
| 净利润同比 | 108.0% | — |
| 每股收益（稀释后） | $0.08 | $-0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRVATDOC
| Q4 25 | $541.2M | $642.3M | ||
| Q3 25 | $580.4M | $626.4M | ||
| Q2 25 | $521.2M | $631.9M | ||
| Q1 25 | $480.1M | $629.4M | ||
| Q4 24 | $460.9M | $640.5M | ||
| Q3 24 | $437.9M | $640.5M | ||
| Q2 24 | $422.3M | $642.4M | ||
| Q1 24 | $415.2M | $646.1M |
净利润PRVATDOC
| Q4 25 | $9.2M | — | ||
| Q3 25 | $6.9M | $-49.5M | ||
| Q2 25 | $2.7M | $-32.7M | ||
| Q1 25 | $4.2M | $-93.0M | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $3.5M | $-33.3M | ||
| Q2 24 | $3.5M | $-837.7M | ||
| Q1 24 | $3.0M | $-81.9M |
营业利润率PRVATDOC
| Q4 25 | 2.1% | -5.6% | ||
| Q3 25 | 2.5% | -8.3% | ||
| Q2 25 | 0.6% | -8.6% | ||
| Q1 25 | 1.1% | -19.2% | ||
| Q4 24 | 1.1% | -7.5% | ||
| Q3 24 | 1.3% | -6.9% | ||
| Q2 24 | 1.2% | -130.9% | ||
| Q1 24 | 0.2% | -13.5% |
净利率PRVATDOC
| Q4 25 | 1.7% | — | ||
| Q3 25 | 1.2% | -7.9% | ||
| Q2 25 | 0.5% | -5.2% | ||
| Q1 25 | 0.9% | -14.8% | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.8% | -5.2% | ||
| Q2 24 | 0.8% | -130.4% | ||
| Q1 24 | 0.7% | -12.7% |
每股收益（稀释后）PRVATDOC
| Q4 25 | $0.08 | $-0.14 | ||
| Q3 25 | $0.05 | $-0.28 | ||
| Q2 25 | $0.02 | $-0.19 | ||
| Q1 25 | $0.03 | $-0.53 | ||
| Q4 24 | $0.03 | $-0.27 | ||
| Q3 24 | $0.03 | $-0.19 | ||
| Q2 24 | $0.03 | $-4.92 | ||
| Q1 24 | $0.02 | $-0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $479.7M | $781.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $737.2M | $1.4B |
| 总资产 | $1.4B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRVATDOC
| Q4 25 | $479.7M | $781.1M | ||
| Q3 25 | $441.4M | $726.2M | ||
| Q2 25 | $390.1M | $679.6M | ||
| Q1 25 | $469.3M | $1.2B | ||
| Q4 24 | $491.1M | $1.3B | ||
| Q3 24 | $422.0M | $1.2B | ||
| Q2 24 | $387.4M | $1.2B | ||
| Q1 24 | $351.1M | $1.1B |
股东权益PRVATDOC
| Q4 25 | $737.2M | $1.4B | ||
| Q3 25 | $709.1M | $1.4B | ||
| Q2 25 | $682.9M | $1.4B | ||
| Q1 25 | $659.4M | $1.4B | ||
| Q4 24 | $635.2M | $1.5B | ||
| Q3 24 | $614.9M | $1.5B | ||
| Q2 24 | $595.4M | $1.5B | ||
| Q1 24 | $576.8M | $2.3B |
总资产PRVATDOC
| Q4 25 | $1.4B | $2.9B | ||
| Q3 25 | $1.4B | $2.9B | ||
| Q2 25 | $1.3B | $2.9B | ||
| Q1 25 | $1.2B | $3.4B | ||
| Q4 24 | $1.1B | $3.5B | ||
| Q3 24 | $1.1B | $3.5B | ||
| Q2 24 | $1.1B | $3.5B | ||
| Q1 24 | $1.0B | $4.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $127.5M | $87.7M |
| 自由现金流经营现金流 - 资本支出 | — | $85.1M |
| 自由现金流率自由现金流/营收 | — | 13.3% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | 13.93× | — |
| 过去12个月自由现金流最近4个季度 | — | $285.5M |
8季度趋势，按日历期对齐
经营现金流PRVATDOC
| Q4 25 | $127.5M | $87.7M | ||
| Q3 25 | $52.0M | $99.3M | ||
| Q2 25 | $8.0M | $91.4M | ||
| Q1 25 | $-24.1M | $15.9M | ||
| Q4 24 | $74.8M | $85.9M | ||
| Q3 24 | $33.2M | $110.2M | ||
| Q2 24 | $34.5M | $88.7M | ||
| Q1 24 | $-33.1M | $8.9M |
自由现金流PRVATDOC
| Q4 25 | — | $85.1M | ||
| Q3 25 | — | $97.0M | ||
| Q2 25 | — | $90.2M | ||
| Q1 25 | — | $13.2M | ||
| Q4 24 | — | $79.8M | ||
| Q3 24 | — | $108.6M | ||
| Q2 24 | — | $86.8M | ||
| Q1 24 | — | $7.8M |
自由现金流率PRVATDOC
| Q4 25 | — | 13.3% | ||
| Q3 25 | — | 15.5% | ||
| Q2 25 | — | 14.3% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 12.5% | ||
| Q3 24 | — | 17.0% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | — | 1.2% |
资本支出强度PRVATDOC
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.2% |
现金转化率PRVATDOC
| Q4 25 | 13.93× | — | ||
| Q3 25 | 7.58× | — | ||
| Q2 25 | 2.97× | — | ||
| Q1 25 | -5.70× | — | ||
| Q4 24 | 17.00× | — | ||
| Q3 24 | 9.38× | — | ||
| Q2 24 | 9.94× | — | ||
| Q1 24 | -11.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
TDOC
| Teladoc Health Integrated Care | $409.1M | 64% |
| Better Help | $233.2M | 36% |
